Brief: Suven Life Sciences secures product patents in India, Japan
25/09/2017 07:20
Sept 25 (Reuters) - Suven Life Sciences Ltd SUVP.NS :
* Says Suven Life Sciences secures product patents in India
and Japan
* Patents correspond to new chemical entities to treat
neurodegenerative disorders; patents valid through 2027 and 2032
respectively
Source text: http://bit.ly/2frIjva
Further company coverage: SUVP.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Suven Life Sciences
See all newsBrief: Suven Life Sciences Completes Patient Enrollment In Global Phase-3 Masupirdine Study
India's Suven Life Sciences gains after Masupirdine Phase-3 study completes patient enrollment
Brief: Suven Life Sciences Completes Phase-1 Study Of SUVN-I6107, Advances To Phase-2
Brief: Suven Life Sciences Reports Positive DSMB Safety Review For Phase-3 Masupirdine Study
Brief: Suven Life Sciences Records 100% Patient Enrolment Milestone In Phase-2B Clinical Trial Of Ropanicant